Cargando…

The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma

N7-methylguanosine (m(7)G) modification on internal RNA positions plays a vital role in several biological processes. Recent research shows m(7)G modification is associated with multiple cancers. However, in hepatocellular carcinoma (HCC), its implications remain to be determined. In this place, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxing, Yao, Shibin, Sun, Zhijuan, Wang, Yanjun, Yue, Jili, Cui, Yongkang, Yu, Chengping, Xu, Haozhi, Li, Linqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478798/
https://www.ncbi.nlm.nih.gov/pubmed/36118897
http://dx.doi.org/10.3389/fgene.2022.894325
_version_ 1784790653765419008
author Chen, Jianxing
Yao, Shibin
Sun, Zhijuan
Wang, Yanjun
Yue, Jili
Cui, Yongkang
Yu, Chengping
Xu, Haozhi
Li, Linqiang
author_facet Chen, Jianxing
Yao, Shibin
Sun, Zhijuan
Wang, Yanjun
Yue, Jili
Cui, Yongkang
Yu, Chengping
Xu, Haozhi
Li, Linqiang
author_sort Chen, Jianxing
collection PubMed
description N7-methylguanosine (m(7)G) modification on internal RNA positions plays a vital role in several biological processes. Recent research shows m(7)G modification is associated with multiple cancers. However, in hepatocellular carcinoma (HCC), its implications remain to be determined. In this place, we need to interrogate the mRNA patterns for 29 key regulators of m(7)G RNA modification and assess their prognostic value in HCC. Initial, the details from The Cancer Genome Atlas (TCGA) database concerning transcribed gene data and clinical information of HCC patients were inspected systematically. Second, according to the mRNA profiles of 29 m(7)G RNA methylation regulators, two clusters (named 1 and 2, respectively) were identified by consensus clustering. Furthermore, robust risk signature for seven m(7)G RNA modification regulators was constructed. Last, we used the Gene Expression Omnibus (GEO) dataset to validate the prognostic associations of the seven-gene risk signature. We figured out that 24/29 key regulators of m(7)G RNA modification varied remarkably in their grades of expression between the HCC and the adjacent tumor control tissues. Cluster one compared with cluster two had a substandard prognosis and was also positively correlated with T classification (T), pathological stage, and vital status (fustat) significantly. Consensus clustering results suggested the expression pattern of m(7)G RNA modification regulators was correlated with the malignancy of HCC strongly. In addition, cluster one was extensively enriched in metabolic-related pathways. Seven optimal genes (METTL1, WDR4, NSUN2, EIF4E, EIF4E2, NCBP1, and NCBP2) were selected to establish the risk model for HCC. Indicating by further analyses and validation, the prognostic model has fine anticipating command and this probability signature might be a self supporting presage factor for HCC. Finally, a new prognostic nomogram based on age, gender, pathological stage, histological grade, and prospects were established to forecast the prognosis of HCC patients accurately. In essence, we detected association of HCC severity and expression levels of m(7)G RNA modification regulators, and developed a risk score model for predicting prognosis of HCC patients’ progression.
format Online
Article
Text
id pubmed-9478798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94787982022-09-17 The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma Chen, Jianxing Yao, Shibin Sun, Zhijuan Wang, Yanjun Yue, Jili Cui, Yongkang Yu, Chengping Xu, Haozhi Li, Linqiang Front Genet Genetics N7-methylguanosine (m(7)G) modification on internal RNA positions plays a vital role in several biological processes. Recent research shows m(7)G modification is associated with multiple cancers. However, in hepatocellular carcinoma (HCC), its implications remain to be determined. In this place, we need to interrogate the mRNA patterns for 29 key regulators of m(7)G RNA modification and assess their prognostic value in HCC. Initial, the details from The Cancer Genome Atlas (TCGA) database concerning transcribed gene data and clinical information of HCC patients were inspected systematically. Second, according to the mRNA profiles of 29 m(7)G RNA methylation regulators, two clusters (named 1 and 2, respectively) were identified by consensus clustering. Furthermore, robust risk signature for seven m(7)G RNA modification regulators was constructed. Last, we used the Gene Expression Omnibus (GEO) dataset to validate the prognostic associations of the seven-gene risk signature. We figured out that 24/29 key regulators of m(7)G RNA modification varied remarkably in their grades of expression between the HCC and the adjacent tumor control tissues. Cluster one compared with cluster two had a substandard prognosis and was also positively correlated with T classification (T), pathological stage, and vital status (fustat) significantly. Consensus clustering results suggested the expression pattern of m(7)G RNA modification regulators was correlated with the malignancy of HCC strongly. In addition, cluster one was extensively enriched in metabolic-related pathways. Seven optimal genes (METTL1, WDR4, NSUN2, EIF4E, EIF4E2, NCBP1, and NCBP2) were selected to establish the risk model for HCC. Indicating by further analyses and validation, the prognostic model has fine anticipating command and this probability signature might be a self supporting presage factor for HCC. Finally, a new prognostic nomogram based on age, gender, pathological stage, histological grade, and prospects were established to forecast the prognosis of HCC patients accurately. In essence, we detected association of HCC severity and expression levels of m(7)G RNA modification regulators, and developed a risk score model for predicting prognosis of HCC patients’ progression. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9478798/ /pubmed/36118897 http://dx.doi.org/10.3389/fgene.2022.894325 Text en Copyright © 2022 Chen, Yao, Sun, Wang, Yue, Cui, Yu, Xu and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Chen, Jianxing
Yao, Shibin
Sun, Zhijuan
Wang, Yanjun
Yue, Jili
Cui, Yongkang
Yu, Chengping
Xu, Haozhi
Li, Linqiang
The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
title The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
title_full The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
title_fullStr The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
title_full_unstemmed The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
title_short The pattern of expression and prognostic value of key regulators for m(7)G RNA methylation in hepatocellular carcinoma
title_sort pattern of expression and prognostic value of key regulators for m(7)g rna methylation in hepatocellular carcinoma
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478798/
https://www.ncbi.nlm.nih.gov/pubmed/36118897
http://dx.doi.org/10.3389/fgene.2022.894325
work_keys_str_mv AT chenjianxing thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT yaoshibin thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT sunzhijuan thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT wangyanjun thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT yuejili thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT cuiyongkang thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT yuchengping thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT xuhaozhi thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT lilinqiang thepatternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT chenjianxing patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT yaoshibin patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT sunzhijuan patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT wangyanjun patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT yuejili patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT cuiyongkang patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT yuchengping patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT xuhaozhi patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma
AT lilinqiang patternofexpressionandprognosticvalueofkeyregulatorsform7grnamethylationinhepatocellularcarcinoma